To further validate the molecular signature that regulates invasiveness in bladder cancer, we used data from a patient cohort (n = 165)14, in which a correlation between E2F1 expression and superficial to invasive progression was observed (GEO id: GSE13507). Here, E2F1 is linked to urinary bladder cancer.